146 related articles for article (PubMed ID: 29443401)
1. Pediatric Intestinal Failure-Associated Liver Disease: Challenges in Identifying Clinically Relevant Biomarkers.
Gura KM; Mulberg AE; Mitchell PD; Yap J; Kim CY; Chen M; Potemkin A; Puder M
JPEN J Parenter Enteral Nutr; 2018 Feb; 42(2):455-462. PubMed ID: 29443401
[TBL] [Abstract][Full Text] [Related]
2. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
[TBL] [Abstract][Full Text] [Related]
3. Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure.
Mutanen A; Lohi J; Merras-Salmio L; Koivusalo A; Pakarinen MP
J Hepatol; 2021 Mar; 74(3):593-602. PubMed ID: 33002568
[TBL] [Abstract][Full Text] [Related]
4. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.
Nandivada P; Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Carlson SJ; Dao DT; Fell GL; Gura KM; Puder M
Am J Clin Nutr; 2016 Sep; 104(3):663-70. PubMed ID: 27510535
[TBL] [Abstract][Full Text] [Related]
5. Effect of a fish oil-based lipid emulsion on intestinal failure-associated liver disease in children.
Zhang T; Wang N; Yan W; Lu L; Tao Y; Li F; Wang Y; Cai W
Eur J Clin Nutr; 2018 Oct; 72(10):1364-1372. PubMed ID: 29382923
[TBL] [Abstract][Full Text] [Related]
6. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
7. Phytosterolemia and γ-glutamyl transferase in adults with parenteral nutrition: Fish versus vegetal lipids: A randomized clinical trial.
Llop-Talaveron J; Badía-Tahull M; Lozano-Andreu T; Rigo-Bonnin R; Virgili-Casas N; Farran-Teixidó L; Miró-Martín M; Suárez-Lledó A; Leiva-Badosa E
Nutrition; 2020 Feb; 70():110587. PubMed ID: 31743812
[TBL] [Abstract][Full Text] [Related]
8. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.
Lauriti G; Zani A; Aufieri R; Cananzi M; Chiesa PL; Eaton S; Pierro A
JPEN J Parenter Enteral Nutr; 2014 Jan; 38(1):70-85. PubMed ID: 23894170
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA 122 Reflects Liver Injury in Children with Intestinal Failure-Associated Liver Disease Treated with Intravenous Fish Oil.
Calkins KL; Thamotharan S; Ghosh S; Dai Y; Devaskar SU
J Nutr; 2020 May; 150(5):1144-1150. PubMed ID: 32072161
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
[TBL] [Abstract][Full Text] [Related]
11. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
12. Hypercholesterolemia and hypertriglyceridemia as risk factors of liver dysfunction in children with inflammation receiving total parenteral nutrition.
Golucci APBS; Morcillo AM; Hortencio TDR; Ribeiro AF; Nogueira RJN
Clin Nutr ESPEN; 2018 Feb; 23():148-155. PubMed ID: 29460791
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria.
Sasdelli AS; Agostini F; Pazzeschi C; Guidetti M; Lal S; Pironi L
Clin Nutr; 2019 Jun; 38(3):1198-1205. PubMed ID: 29778510
[TBL] [Abstract][Full Text] [Related]
14. The extent of intestinal failure-associated liver disease in patients referred for intestinal rehabilitation is associated with increased mortality: an analysis of the Pediatric Intestinal Failure Consortium database.
Javid PJ; Oron AP; Duggan CP; Squires RH; Horslen SP;
J Pediatr Surg; 2018 Jul; 53(7):1399-1402. PubMed ID: 28943136
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of serum fibroblast growth factor 19 and liver stiffness for intestinal failure associated liver disease-cholestasis.
Xiao Y; Maitiabula G; Wang H; Xu K; Zhang Y; Fu N; Zhang L; Gao T; Sun G; Song D; Gao X; Wang X
Clin Nutr ESPEN; 2024 Feb; 59():89-95. PubMed ID: 38220411
[TBL] [Abstract][Full Text] [Related]
16. Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study.
Fragkos KC; Picasso Bouroncle MC; Kumar S; Caselton L; Menys A; Bainbridge A; Taylor SA; Torrealdea F; Kumagai T; Di Caro S; Rahman F; Macnaughtan J; Chouhan MD; Mehta S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32707726
[TBL] [Abstract][Full Text] [Related]
17. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
[TBL] [Abstract][Full Text] [Related]
18. Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease.
Koelfat KVK; Schaap FG; Hodin CMJM; Visschers RGJ; Svavarsson BI; Lenicek M; Shiri-Sverdlov R; Lenaerts K; Olde Damink SWM
Clin Nutr; 2017 Oct; 36(5):1403-1410. PubMed ID: 28029505
[TBL] [Abstract][Full Text] [Related]
19. Marked Increase of Gamma-Glutamyltransferase as an Indicator of Drug-Induced Liver Injury in Patients without Conventional Diagnostic Criteria of Acute Liver Injury.
Weber S; Allgeier J; Denk G; Gerbes AL
Visc Med; 2022 Jun; 38(3):223-228. PubMed ID: 35814980
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review: Noninvasive Assessments of Intestinal Failure-Associated Liver Disease in the Adult Population.
Huijbers A; Koggel LM; Bronkhorst C; Verheij J; Wanten GJA
JPEN J Parenter Enteral Nutr; 2019 Jul; 43(5):615-626. PubMed ID: 30937931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
